Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses

H.G. Otten; G.C. de Gast; W.C. Vooijs; A.P. van der Gouw; M. de Boer; M.A. Ossevoort; M. Jonker

Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses

Translated title of the contribution: Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses

H.G. Otten, G.C. de Gast, W.C. Vooijs, A.P. van der Gouw, M. de Boer, M.A. Ossevoort, M. Jonker

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses
Original language	Undefined/Unknown
Pages (from-to)	569-575
Number of pages	7
Journal	Cancer Immunology, Immunotherapy
Volume	52
Publication status	Published - 2003

Cite this

@article{11ee333c65e0479e9a34d72b754d2009,

title = "Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses",

author = "H.G. Otten and {de Gast}, G.C. and W.C. Vooijs and {van der Gouw}, A.P. and {de Boer}, M. and M.A. Ossevoort and M. Jonker",

year = "2003",

language = "Undefined/Unknown",

volume = "52",

pages = "569--575",

journal = "Cancer Immunology, Immunotherapy",

issn = "0340-7004",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses

AU - Otten, H.G.

AU - de Gast, G.C.

AU - Vooijs, W.C.

AU - van der Gouw, A.P.

AU - de Boer, M.

AU - Ossevoort, M.A.

AU - Jonker, M.

PY - 2003

Y1 - 2003

M3 - Article

SN - 0340-7004

VL - 52

SP - 569

EP - 575

JO - Cancer Immunology, Immunotherapy

JF - Cancer Immunology, Immunotherapy

ER -